Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Moisture Analyzer Safeguards Drug Performance with Enhanced Precision

Published: Monday, April 22, 2013
Last Updated: Monday, April 22, 2013
Bookmark and Share
New moisture analyzer helps to ensure pharmaceutical quality.

Mettler Toledo has announced the launch of its new Excellence HX204 Moisture Analyzer.

This analyzer, driven by a halogen heating system, helps pharmaceutical manufacturers assure product quality, meet compliance requirements, save money through reduced rework, and save time for enhanced productivity.

Full process control during testing is crucial to safe pharmaceutical manufacturing. With Excellence HX204, this control is assured through a multi-faceted adjustment process.

The HX204 can be tested and adjusted at operating temperature, ensuring correct performance at specified operating conditions. Additionally, built-in LevelControl instantly warns users if the instrument is off-level.

These features help to ensure that the high-performance MonoBloc weighing cell - which offers a capacity of 200g and 0.1 mg resolution - can guarantee maximum weighing accuracy for reliable, reproducible results.

Ease-of-use with the Excellence HX204 also virtually guarantees enhanced lab productivity. Fully automatic calibration technology (FACT) eliminates time-consuming frequent manual testing with external weights.

Personalized home screens and individual rights assignment allow quick access to necessary operations; the user sees only the information he needs and is authorized to access, practically eliminating handling errors.

Real-time graphics with integrated control charts show drying curves and measure trends for fast analysis. An ability to set individual, product specific control limits also facilitates easy pass/fail determinations.

All of these features add up to precise moisture analysis, which is critical to ensuring drug performance and consumer safety.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pharma Tech Trends and Development Cost Solutions
METTLER TOLEDO’s new on-demand webinar, “Methods to Improve Chemical Process Development,” takes on the challenges of today’s pharmaceutical market.
Thursday, April 04, 2013
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos